Search - tctmd.com

Displaying 421 - 440 of 814

Sort: Relevancy | Date

Presentation NY Valves 2024

TMVR Following Failed M-TEER: Technical and Procedural Considerations

Presenter: Rodrigo D. Estevez-Loureiro

June 06, 2024

Presentation NY Valves 2024

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

Presenter: Jörg Hausleiter

June 06, 2024

Presentation NY Valves 2024

TAVR Will Have a Longer Lasting Durability Than SAVR

Presenter: Michael J. Reardon

June 06, 2024

Presentation NY Valves 2024

My First Choice Would Be Balloon Expandable Valves!

Presenter: Helene Eltchaninoff

June 06, 2024

Presentation NY Valves 2024

JenaValve

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

Designing Trials to Assess the Effectiveness of New VHD Screening Strategies

Presenter: Timothy Joseph Poterucha

June 06, 2024

Presentation NY Valves 2024

TAVI Valve-in-Valve-in-Valve: A Case Report of Viv Redo Procedure

Presenter: Maciej Mazurek

June 06, 2024

Presentation NY Valves 2024

SMART Says That Self Expanding Valves Are Best!

Presenter: Howard C. Herrmann

June 06, 2024

Presentation NY Valves 2024

Metanalysis of Clinical and Hemodynamic Differences in Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus

Presenter: Errol Christopher Moras

June 06, 2024

Presentation NY Valves 2024

Gradients After Transcatheter Aortic Valve Replacements Are Impacted by Both Body Mass Index and Valve Size

Presenter: Akhil Reddy

June 06, 2024

Presentation NY Valves 2024

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Presenter: Mark Lebehn

June 06, 2024

Presentation NY Valves 2024

Bioprosthetic Valve Fracture for Mitral ViV Therapy: Indication, Technique and Outcomes

Presenter: John Thomas Saxon

June 06, 2024

Presentation NY Valves 2024

TRISCEND II: Understanding the Study Design and Interpreting the Results

Presenter: Susheel K. Kodali

June 06, 2024

Presentation NY Valves 2024

Cases 1/2 : TAVR at 8 Years and SVD at 2 Years

Presenter: Guillaume Bonnet

June 06, 2024

Presentation NY Valves 2024

SIEGEL TAVR: A Revolutionary Ultra-Low Profile Aortic Valve Based Upon Rhenium Superalloys (Mirus)

Presenter: Pradeep K. Yadav

June 06, 2024

Presentation NY Valves 2024

Case Presentation 2: Transcatheter Tricuspid Valve Replacement With Evoque in a Patient With CIED-Related TR

Presenter: Charles J. Davidson

June 06, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli: A Propensity-Matched Analysis of Gender-Based Outcomes

Presenter: Danial Ahmad

June 06, 2024

Presentation NY Valves 2024

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Presenter: Jonathan Curio

June 06, 2024

Presentation NY Valves 2024

Echo-Derived Gradients Increase at 30 Days in Most Patients After Balloon-Expandable TAVR Irrespective of Valve Type and Valve Size

Presenter: Spencer Ng

June 06, 2024

Presentation NY Valves 2024

Screening for VHD: Beyond Proof of Concept to Implementation and Scaling

Presenter: Sammy Elmariah

June 06, 2024

Advertisement

TMVR Following Failed M-TEER: Technical and Procedural Considerations

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

TAVR Will Have a Longer Lasting Durability Than SAVR

My First Choice Would Be Balloon Expandable Valves!

JenaValve

Designing Trials to Assess the Effectiveness of New VHD Screening Strategies

TAVI Valve-in-Valve-in-Valve: A Case Report of Viv Redo Procedure

SMART Says That Self Expanding Valves Are Best!

Metanalysis of Clinical and Hemodynamic Differences in Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus

Gradients After Transcatheter Aortic Valve Replacements Are Impacted by Both Body Mass Index and Valve Size

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Bioprosthetic Valve Fracture for Mitral ViV Therapy: Indication, Technique and Outcomes

TRISCEND II: Understanding the Study Design and Interpreting the Results

Cases 1/2 : TAVR at 8 Years and SVD at 2 Years

SIEGEL TAVR: A Revolutionary Ultra-Low Profile Aortic Valve Based Upon Rhenium Superalloys (Mirus)

Case Presentation 2: Transcatheter Tricuspid Valve Replacement With Evoque in a Patient With CIED-Related TR

Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli: A Propensity-Matched Analysis of Gender-Based Outcomes

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Echo-Derived Gradients Increase at 30 Days in Most Patients After Balloon-Expandable TAVR Irrespective of Valve Type and Valve Size

Screening for VHD: Beyond Proof of Concept to Implementation and Scaling

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content